ATE400279T1 - Verwendung der sulfatierten polysacchariden zur behandlung von thrombosen - Google Patents

Verwendung der sulfatierten polysacchariden zur behandlung von thrombosen

Info

Publication number
ATE400279T1
ATE400279T1 AT00960777T AT00960777T ATE400279T1 AT E400279 T1 ATE400279 T1 AT E400279T1 AT 00960777 T AT00960777 T AT 00960777T AT 00960777 T AT00960777 T AT 00960777T AT E400279 T1 ATE400279 T1 AT E400279T1
Authority
AT
Austria
Prior art keywords
thrombosis
treatment
sulfated polysaccharides
arterial
polysaccharide
Prior art date
Application number
AT00960777T
Other languages
English (en)
Inventor
Sylvia Colliec-Jouault
Patrick Durand
Anne-Marie Fischer
Jacqueline Jozefonvicz
Didier Letourneur
Jean Millet
Original Assignee
Ifremer
Centre Nat Rech Scient
Univ Paris Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ifremer, Centre Nat Rech Scient, Univ Paris Descartes filed Critical Ifremer
Application granted granted Critical
Publication of ATE400279T1 publication Critical patent/ATE400279T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
AT00960777T 1999-09-01 2000-09-01 Verwendung der sulfatierten polysacchariden zur behandlung von thrombosen ATE400279T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910965A FR2797768B1 (fr) 1999-09-01 1999-09-01 Utilisation d'un polysaccharide sulfate de bas poids moleculaire pour l'obtention d'un medicament actif contre la thrombose vasculaire

Publications (1)

Publication Number Publication Date
ATE400279T1 true ATE400279T1 (de) 2008-07-15

Family

ID=9549460

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00960777T ATE400279T1 (de) 1999-09-01 2000-09-01 Verwendung der sulfatierten polysacchariden zur behandlung von thrombosen

Country Status (8)

Country Link
US (1) US6828307B1 (de)
EP (1) EP1207891B1 (de)
AT (1) ATE400279T1 (de)
AU (1) AU7296600A (de)
DE (1) DE60039437D1 (de)
ES (1) ES2310172T3 (de)
FR (1) FR2797768B1 (de)
WO (1) WO2001015654A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2871379B1 (fr) 2004-06-14 2006-09-29 Ifremer Utilisation de derives polysaccharidiques hautement sulfates et de faible masse molaire pour moduler l'angiogenese
FR2871476B1 (fr) * 2004-06-14 2011-04-01 Ifremer Derives depolymerises sulfates d'exopolysaccharides (eps) provenant de bacteries marines mesophiles, leur procede de preparation et leurs utilisations en regeneration tissulaire
FR2897538B1 (fr) * 2006-02-23 2008-05-02 Univ Paris Descartes Utilisation de fucanes a des fins de greffe, d'ingenierie et de regeneration osseuses
US20090318855A1 (en) * 2008-06-24 2009-12-24 Abbott Cardiovascular Systems Inc. Devices and methods for improving intravascular uptake of agents
FR3055549A1 (fr) 2016-09-02 2018-03-09 Universite Blaise Pascal-Clermont-Ferrand Ii Polysaccharide sulfate extrait d'une algue rouge pour son utilisation en tant qu'anticoagulant
FR3079831B1 (fr) 2018-04-05 2020-11-20 Jymsea Procede d’extraction d’oligofucanes et ses applications
CR20210059A (es) * 2018-06-28 2021-12-23 Marizyme Biotech Composiciones farmacéuticas y métodos para el tratamientos de la trombosis y administración a través de dispositivos médicos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533549A (en) * 1983-01-04 1985-08-06 Lasker Sigmund E Antithrombotic agent
FR2572731B1 (fr) * 1984-11-07 1987-03-06 Sanofi Sa Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale
AU634521B2 (en) * 1989-02-06 1993-02-25 Taiho Pharmaceutical Co., Ltd. New sulfated polysaccharide, pharmaceutically acceptable salts thereof, preparation thereof, and drug containing the same as active ingredient
FR2648463B1 (fr) * 1989-06-14 1993-01-22 Inst Fs Rech Expl Mer Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention
US5458568A (en) * 1991-05-24 1995-10-17 Cortrak Medical, Inc. Porous balloon for selective dilatation and drug delivery
FR2738009B1 (fr) * 1995-08-24 1997-10-31 Centre Nat Rech Scient Procede d'obtention de polysaccharides sulfates
IT1288713B1 (it) * 1996-12-18 1998-09-23 Crinos Industria Farmaco Fucani a basso peso molecolare aventi attivita' anticoagulante antitrombinica e antitrombotica

Also Published As

Publication number Publication date
ES2310172T3 (es) 2009-01-01
DE60039437D1 (de) 2008-08-21
EP1207891B1 (de) 2008-07-09
AU7296600A (en) 2001-03-26
WO2001015654A2 (fr) 2001-03-08
FR2797768A1 (fr) 2001-03-02
US6828307B1 (en) 2004-12-07
WO2001015654A3 (fr) 2001-06-07
EP1207891A2 (de) 2002-05-29
FR2797768B1 (fr) 2003-06-13

Similar Documents

Publication Publication Date Title
DK0971961T3 (da) N-sulfaterede hyaluronsyreforbindelser, derivater deraf og en fremgangsmåde til deres fremstilling
NO861624L (no) Roerformet proteseartikkel.
ATE481478T1 (de) Rationell konstruierte, von chondroitinase b abgeleitete lyasen
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
ATE259830T1 (de) Polymerkomplexe von glukuronoglukanen
NO20021281L (no) Vaskul¶r beleggingssammensetning
SE9101957D0 (sv) Blandningar av polysackarider med laag molekylvikt samt framstaellning och anvaendning av desamma
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
ATE406909T1 (de) Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
DE60125154D1 (de) Teildesulfatierte glykosaminoglykanderivate mit antiangiogenischer aktivität und ohne antikoagulierender wirkung
ATE411016T1 (de) Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
ITMI931518A1 (it) Derivati eparinici ad attivita' antimetastatica
DE60039437D1 (de) Verwendung der sulfatierten polysacchariden zur behandlung von thrombosen
ES2167748T3 (es) Derivados del polisacarido k5 con actividad anticoagulante.
DE69841041D1 (de) Stent beschichtet mit dna
EA200400464A1 (ru) Способы и композиции новых триазиновых соединений
DE69425820D1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
BR9917495A (pt) Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores
MY120530A (en) Combination preparation for use in dementia
DE60320931D1 (de) Verwendung von sulfatierten glykosaminoglykanen zur herbeiführung von effektiven wehen bei frauen
ATE361071T1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
MX9304626A (es) Derivados heterociclicos utiles en el tratamiento de enfermedades cardiovasculares.
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
NO20004393D0 (no) Anvendelse av CD137 for Õ fremme proliferering av perifere monocytter
ATE321064T1 (de) Sulfatierte polysaccharide und verfahren zur behandlung von entzündungen unter verwendung derselben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties